These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 10624967

  • 1. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels.
    Kersten JR, Montgomery MW, Pagel PS, Warltier DC.
    Anesth Analg; 2000 Jan; 90(1):5-11. PubMed ID: 10624967
    [Abstract] [Full Text] [Related]

  • 2. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model.
    Busk M, Maeng M, Kristensen J, Berg JS, Mortensen UM, Nielsen TT, Nielsen-Kudsk JE.
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):335-42. PubMed ID: 17122904
    [Abstract] [Full Text] [Related]

  • 3. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP, Pagel PS, Tessmer JP, Warltier DC.
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [Abstract] [Full Text] [Related]

  • 4. [Is levosimendan an inoprotective drug in patients with acute coronary syndrome undergoing surgical revascularization?].
    Lehmann A, Boldt J, Lang J, Isgro F, Blome M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):577-82. PubMed ID: 12975736
    [Abstract] [Full Text] [Related]

  • 5. Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels: mechanism of desflurane-induced cardioprotection.
    Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DC.
    Anesthesiology; 2000 Jun; 92(6):1731-9. PubMed ID: 10839925
    [Abstract] [Full Text] [Related]

  • 6. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs.
    Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC.
    Anesthesiology; 1999 Nov; 91(5):1437-46. PubMed ID: 10551596
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM.
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
    [Abstract] [Full Text] [Related]

  • 9. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS, Harkin CP, Hettrick DA, Warltier DC.
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [Abstract] [Full Text] [Related]

  • 10. The effects of a newly synthesized ATP-sensitive potassium channel opener, MJ-355, on blood pressure and myocardial ischemia-reperfusion injury in rats.
    Lee YM, Peng YY, Sheu JR, Cheng CY, Yen MH.
    Jpn J Pharmacol; 1999 Oct; 81(2):185-93. PubMed ID: 10591476
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS, Hettrick DA, Warltier DC.
    Basic Res Cardiol; 1996 Oct; 91(4):296-307. PubMed ID: 8874779
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.
    Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J.
    Cardiovasc Res; 1993 Apr; 27(4):623-9. PubMed ID: 8324796
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.